Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature.

Kelliny, Marc; Croarkin, Paul E; Moore, Katherine M; Bobo, William V

Kelliny, Marc; Croarkin, Paul E; Moore, Katherine M; Bobo, William V.

Afiliação

Kelliny M; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Croarkin PE; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Moore KM; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Bobo WV; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.

Ther Clin Risk Manag ; 11: 1193-212, 2015.

Article em En | MEDLINE | ID: mdl-26316764

Palavras-chave

Lu AA21004; adverse effects/side effects/safety; depression; drug inter-actions; major depression; pharmacokinetics; pharmacological profile; vortioxetine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ther Clin Risk Manag Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google